As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/9/24‡ ReShape Lifesciences Inc.         S-3          5/8/24    4:281K                                   Toppan Merri… Bridge/FA2 
 4/10/24  ReShape Lifesciences Inc.         8-K:3        4/9/24   10:141K                                   Toppan Merrill Bridge/FA 
 4/10/24‡ ReShape Lifesciences Inc.         8-K:4,9      4/8/24   11:229K                                   Toppan Merrill Bridge/FA 
  4/4/24  ReShape Lifesciences Inc.         8-K:2,9      4/1/24   11:361K                                   Toppan Merrill Bridge/FA 
  4/1/24  ReShape Lifesciences Inc.         10-K       12/31/23   82:10M                                    Toppan Merrill Bridge/FA 
 2/26/24  ReShape Lifesciences Inc.         8-K:5       2/23/24   10:172K                                   Toppan Merrill Bridge/FA 
 1/24/24‡ ReShape Lifesciences Inc.         DEF 14A     2/23/24    1:1.1M                                   Toppan Merrill/FA        
 1/18/24  ReShape Lifesciences Inc.         8-K:3,5,9   1/11/24   11:287K                                   Toppan Merrill Bridge/FA 
 1/16/24  Schneid Yair                      3          10% Owner²  1:3K   ReShape Lifesciences Inc.         EdgarAgents LLC/FA       
 1/17/24‡ Schneid Yair                      SC 13G      1/16/24    1:45K  ReShape Lifesciences Inc.         EdgarAgents LLC/FA       
  1/5/24  ReShape Lifesciences Inc.         PRE 14A      1/5/24    1:746K                                   Toppan Merrill/FA        
11/29/23  ReShape Lifesciences Inc.         8-K:1,3,7,911/21/23   13:421K                                   Toppan Merrill Bridge/FA 
 11/9/23‡ ReShape Lifesciences Inc.         10-Q        9/30/23   60:6.2M                                   Toppan Merrill Bridge/FA 
 11/9/23‡ ReShape Lifesciences Inc.         8-K:2,9     11/8/23   11:422K                                   Toppan Merrill Bridge/FA 
 11/8/23  Stankovich Thomas                 4          Officer²    1:8K   ReShape Lifesciences Inc.         Counsell Deanna/FA       
10/13/23  ReShape Lifesciences Inc.         8-K:3      10/10/23   10:186K                                   Toppan Merrill/FA        
 10/5/23  ReShape Lifesciences Inc.         8-K:1,7,9   9/29/23   12:331K                                   Toppan Merrill/FA        
 10/3/23  ReShape Lifesciences Inc.         424B4                  2:973K                                   Toppan Merrill/FA        
 9/29/23‡ ReShape Lifesciences Inc.         EFFECT      9/29/23    1:2K                                     SEC #5                   
 9/28/23  ReShape Lifesciences Inc.         CORRESP¶   10/30/23    1:17K                                    Toppan Merrill/FA        

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	424B4	Prospectus – Info Previously Omitted & New Facts or Events.
	CORRESP	Comment-Response or Other Letter to the SEC.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	EFFECT	SEC Notice of Effectiveness.
	PRE 14A	Preliminary Proxy Statement — Schedule 14A.
	S-3	Registration Statement – Securities for a Transaction — Form S-3.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	¶	This Filing contains a delayed-release Document.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.